Recent supplement of the journal notes that Immuknow produced by Cylex has not prospective multicenter studies to determine its abilit to assess rejection risk. OOps
Re: Stock Sale How many know about this SEC filing? CYLEX INC FORM D/A (Amended Small Company Offering and Sale of Securities Without Registration) Filed 09/02/10 Address 8980-1 OLD ANNAPOLIS RD COLUMBIA, MD 21045 Telephone 410-964-0236 CIK 0001111086 Fiscal Year 12/31 http://www. Offering and Sales Amounts Total Offering Amount $ 3300000 USD Indefinite Total Amount Sold $ 3300000 USD Sales Commissions $ 0 USD Estimate Finders' Fees $ 30000 USD Estimate
What is the current or most recent spin on ImmuKnow by the leadership. Is this a temporary jobs program? Can this business model survive on the revenue from this test? Any off-label sales and marketing issues yet?
Re: Stock Sale That makes sense. $20M in 07 of which 6 was already spent so a burn of 14M over 5 years or almost 3M a year. Wonder how many more years left of this and the leaders.
